These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10924776)

  • 1. The role of mineralocorticoid receptors in the circadian activity of the human hypothalamus-pituitary-adrenal system: effect of age.
    Heuser I; Deuschle M; Weber A; Kniest A; Ziegler C; Weber B; Colla M
    Neurobiol Aging; 2000; 21(4):585-9. PubMed ID: 10924776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineralocorticoid receptor also modulates basal activity of hypothalamus-pituitary-adrenocortical system in humans.
    Deuschle M; Weber B; Colla M; Müller M; Kniest A; Heuser I
    Neuroendocrinology; 1998 Nov; 68(5):355-60. PubMed ID: 9822803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of mineralocorticoid receptors in hypothalamic-pituitary-adrenal axis regulation in humans.
    Young EA; Lopez JF; Murphy-Weinberg V; Watson SJ; Akil H
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3339-45. PubMed ID: 9745451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamus-pituitary-adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade.
    Giordano R; Bo M; Pellegrino M; Vezzari M; Baldi M; Picu A; Balbo M; Bonelli L; Migliaretti G; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5656-62. PubMed ID: 16014406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased activity of the hypothalamus-pituitary-adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone.
    Heuser I; Deuschle M; Weber B; Stalla GK; Holsboer F
    Psychoneuroendocrinology; 2000 Jul; 25(5):513-8. PubMed ID: 10818284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamic-pituitary-adrenal axis in humans.
    Berardelli R; Karamouzis I; Marinazzo E; Prats E; Picu A; Giordano R; Ghigo E; Arvat E
    Eur J Endocrinol; 2010 Jun; 162(6):1067-74. PubMed ID: 20219855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined receptor antagonist stimulation of the hypothalamic-pituitary-adrenal axis test identifies impaired negative feedback sensitivity to cortisol in obese men.
    Mattsson C; Reynolds RM; Simonyte K; Olsson T; Walker BR
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1347-52. PubMed ID: 19141586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity.
    Spencer RL; Kim PJ; Kalman BA; Cole MA
    Endocrinology; 1998 Jun; 139(6):2718-26. PubMed ID: 9607777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone.
    Otte C; Jahn H; Yassouridis A; Arlt J; Stober N; Maass P; Wiedemann K; Kellner M
    Life Sci; 2003 Aug; 73(14):1835-45. PubMed ID: 12888122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid receptor function in major depression.
    Young EA; Lopez JF; Murphy-Weinberg V; Watson SJ; Akil H
    Arch Gen Psychiatry; 2003 Jan; 60(1):24-8. PubMed ID: 12511169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controls.
    Buckley TM; Mullen BC; Schatzberg AF
    Psychoneuroendocrinology; 2007; 32(8-10):859-64. PubMed ID: 17666187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans.
    Arvat E; Maccagno B; Giordano R; Pellegrino M; Broglio F; Gianotti L; Maccario M; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3176-81. PubMed ID: 11443185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. With aging in humans the activity of the hypothalamus-pituitary-adrenal system increases and its diurnal amplitude flattens.
    Deuschle M; Gotthardt U; Schweiger U; Weber B; Körner A; Schmider J; Standhardt H; Lammers CH; Heuser I
    Life Sci; 1997; 61(22):2239-46. PubMed ID: 9393943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of mineralocorticoid receptor function in treatment-resistant depression.
    Juruena MF; Pariante CM; Papadopoulos AS; Poon L; Lightman S; Cleare AJ
    J Psychopharmacol; 2013 Dec; 27(12):1169-79. PubMed ID: 23904409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineralocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis in aged humans.
    Otte C; Yassouridis A; Jahn H; Maass P; Stober N; Wiedemann K; Kellner M
    J Gerontol A Biol Sci Med Sci; 2003 Oct; 58(10):B900-5. PubMed ID: 14570856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment.
    Kudielka BM; Schmidt-Reinwald AK; Hellhammer DH; Kirschbaum C
    Neuroendocrinology; 1999 Dec; 70(6):422-30. PubMed ID: 10657735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of naproxen on the hypothalamic-pituitary-adrenal axis in healthy volunteers.
    Eijsbouts AM; Kempers MJ; Kramer RS; Hopman MT; van den Hoogen FH; Laan RF; Hermus AR; Sweep FC; van de Putte LB
    Br J Clin Pharmacol; 2009 Jan; 67(1):22-8. PubMed ID: 19133058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute HPA axis responses, heart rate, and mood changes to psychosocial stress (TSST) in humans at different times of day.
    Kudielka BM; Schommer NC; Hellhammer DH; Kirschbaum C
    Psychoneuroendocrinology; 2004 Sep; 29(8):983-92. PubMed ID: 15219648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortisol and adrenocorticotropic hormone dynamics in the acute phase of subarachnoid haemorrhage.
    Zetterling M; Engström BE; Hallberg L; Hillered L; Enblad P; Karlsson T; Ronne Engström E
    Br J Neurosurg; 2011 Dec; 25(6):684-92. PubMed ID: 22115015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pituitary-adrenal glucocorticoid response is altered by gender and disease.
    Greenspan SL; Rowe JW; Maitland LA; McAloon-Dyke M; Elahi D
    J Gerontol; 1993 May; 48(3):M72-7. PubMed ID: 8387077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.